drugset / Trial / NCT02468284
Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this trial is to look at how much a new trial drug get into body, such as when the drug concentration in your body reaches peak and how high the peak value is.
Timeline
- Start
- 2015-07
- Primary completion
- 2016-10-13
- Completion
- 2017-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Degarelix | Other / unclassified | 80 mg | — |